These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
273 related articles for article (PubMed ID: 17241098)
1. Impact of integrated PET/CT on variability of target volume delineation in rectal cancer. Patel DA; Chang ST; Goodman KA; Quon A; Thorndyke B; Gambhir SS; McMillan A; Loo BW; Koong AC Technol Cancer Res Treat; 2007 Feb; 6(1):31-6. PubMed ID: 17241098 [TBL] [Abstract][Full Text] [Related]
2. Clinical utility of integrated positron emission tomography/computed tomography imaging in the clinical management and radiation treatment planning of locally advanced rectal cancer. Whaley JT; Fernandes AT; Sackmann R; Plastaras JP; Teo BK; Grover S; Perini RF; Metz JM; Pryma DA; Apisarnthanarax S Pract Radiat Oncol; 2014; 4(4):226-32. PubMed ID: 25012830 [TBL] [Abstract][Full Text] [Related]
3. Target volume delineation for preoperative radiotherapy of rectal cancer: inter-observer variability and potential impact of FDG-PET/CT imaging. Krengli M; Cannillo B; Turri L; Bagnasacco P; Berretta L; Ferrara T; Galliano M; Gribaudo S; Melano A; Munoz F; Sciacero P; Tseroni V; Bassi MC; Brambilla M; Inglese E Technol Cancer Res Treat; 2010 Aug; 9(4):393-8. PubMed ID: 20626204 [TBL] [Abstract][Full Text] [Related]
4. Impact of 18-fluorodeoxyglucose positron emission tomography on computed tomography defined target volumes in radiation treatment planning of esophageal cancer: reduction in geographic misses with equal inter-observer variability: PET/CT improves esophageal target definition. Schreurs LM; Busz DM; Paardekooper GM; Beukema JC; Jager PL; Van der Jagt EJ; van Dam GM; Groen H; Plukker JT; Langendijk JA Dis Esophagus; 2010 Aug; 23(6):493-501. PubMed ID: 20113320 [TBL] [Abstract][Full Text] [Related]
5. Exploring spatial overlap of high-uptake regions derived from dual tracer positron emission tomography-computer tomography imaging using 18F-fluorodeoxyglucose and 18F-fluorodeoxythymidine in nonsmall cell lung cancer patients: a prospective pilot study. Liu J; Li C; Hu M; Lu J; Shi X; Xing L; Sun X; Fu Z; Yu J; Meng X Medicine (Baltimore); 2015 May; 94(17):e678. PubMed ID: 25929896 [TBL] [Abstract][Full Text] [Related]
6. Delineation of gross tumor volume (GTV) for radiation treatment planning of locally advanced rectal cancer using information from MRI or FDG-PET/CT: a prospective study. Brændengen M; Hansson K; Radu C; Siegbahn A; Jacobsson H; Glimelius B Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e439-45. PubMed ID: 21641122 [TBL] [Abstract][Full Text] [Related]
7. Automated functional image-guided radiation treatment planning for rectal cancer. Ciernik IF; Huser M; Burger C; Davis JB; Szekely G Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):893-900. PubMed ID: 15936575 [TBL] [Abstract][Full Text] [Related]
8. The contribution of integrated PET/CT to the evolving definition of treatment volumes in radiation treatment planning in lung cancer. Ashamalla H; Rafla S; Parikh K; Mokhtar B; Goswami G; Kambam S; Abdel-Dayem H; Guirguis A; Ross P; Evola A Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1016-23. PubMed ID: 15979817 [TBL] [Abstract][Full Text] [Related]
9. ¹⁸F-FDG-PET imaging in radiotherapy tumor volume delineation in treatment of head and neck cancer. Delouya G; Igidbashian L; Houle A; Bélair M; Boucher L; Cohade C; Beaulieu S; Filion EJ; Coulombe G; Hinse M; Martel C; Després P; Nguyen-Tan PF Radiother Oncol; 2011 Dec; 101(3):362-8. PubMed ID: 21885143 [TBL] [Abstract][Full Text] [Related]
10. Improving observer variability in target delineation for gastro-oesophageal cancer--the role of (18F)fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography. Vesprini D; Ung Y; Dinniwell R; Breen S; Cheung F; Grabarz D; Kamra J; Mah K; Mansouri A; Pond G; Brock K; Darling G; Knox J; Haider M; Wong RK Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):631-8. PubMed ID: 18755578 [TBL] [Abstract][Full Text] [Related]
11. Variability of gross tumour volume delineation: MRI and CT based tumour and lymph node delineation for lung radiotherapy. Kumar S; Holloway L; Boxer M; Yap ML; Chlap P; Moses D; Vinod S Radiother Oncol; 2022 Feb; 167():292-299. PubMed ID: 34896156 [TBL] [Abstract][Full Text] [Related]
12. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer. Bradley J; Thorstad WL; Mutic S; Miller TR; Dehdashti F; Siegel BA; Bosch W; Bertrand RJ Int J Radiat Oncol Biol Phys; 2004 May; 59(1):78-86. PubMed ID: 15093902 [TBL] [Abstract][Full Text] [Related]
13. Reduction of observer variation using matched CT-PET for lung cancer delineation: a three-dimensional analysis. Steenbakkers RJ; Duppen JC; Fitton I; Deurloo KE; Zijp LJ; Comans EF; Uitterhoeve AL; Rodrigus PT; Kramer GW; Bussink J; De Jaeger K; Belderbos JS; Nowak PJ; van Herk M; Rasch CR Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):435-48. PubMed ID: 16198064 [TBL] [Abstract][Full Text] [Related]
14. 18F-FDG PET definition of gross tumor volume for radiotherapy of lung cancer: is the tumor uptake value-based approach appropriate for lymph node delineation? Rodríguez N; Sanz X; Trampal C; Foro P; Reig A; Lacruz M; Membrive I; Lozano J; Quera J; Algara M Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):659-66. PubMed ID: 20133071 [TBL] [Abstract][Full Text] [Related]
15. Impact of FDG PET/CT on delineation of the gross tumor volume for radiation planning in non-small-cell lung cancer. Spratt DE; Diaz R; McElmurray J; Csiki I; Duggan D; Lu B; Delbeke D Clin Nucl Med; 2010 Apr; 35(4):237-43. PubMed ID: 20305410 [TBL] [Abstract][Full Text] [Related]
17. Geometrical differences in target volumes based on 18F-fluorodeoxyglucose positron emission tomography/computed tomography and four-dimensional computed tomography maximum intensity projection images of primary thoracic esophageal cancer. Guo Y; Li J; Wang W; Zhang Y; Wang J; Duan Y; Shang D; Fu Z Dis Esophagus; 2014; 27(8):744-50. PubMed ID: 24915760 [TBL] [Abstract][Full Text] [Related]
18. Biological image-guided radiotherapy in rectal cancer: is there a role for FMISO or FLT, next to FDG? Roels S; Slagmolen P; Nuyts J; Lee JA; Loeckx D; Maes F; Stroobants S; Penninckx F; Haustermans K Acta Oncol; 2008; 47(7):1237-48. PubMed ID: 18654902 [TBL] [Abstract][Full Text] [Related]
19. Comparison of (18)F-fluorothymidine and (18)F-fluorodeoxyglucose PET/CT in delineating gross tumor volume by optimal threshold in patients with squamous cell carcinoma of thoracic esophagus. Han D; Yu J; Yu Y; Zhang G; Zhong X; Lu J; Yin Y; Fu Z; Mu D; Zhang B; He W; Huo Z; Liu X; Kong L; Zhao S; Sun X Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1235-41. PubMed ID: 19910143 [TBL] [Abstract][Full Text] [Related]
20. 18F-fluorodeoxyglucose positron emission tomography/computed tomography-based radiotherapy target volume definition in non-small-cell lung cancer: delineation by radiation oncologists vs. joint outlining with a PET radiologist? Hanna GG; Carson KJ; Lynch T; McAleese J; Cosgrove VP; Eakin RL; Stewart DP; Zatari A; O'Sullivan JM; Hounsell AR Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1040-51. PubMed ID: 20350798 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]